LFG
VRTX icon

Lockerman Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Lockerman Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-863
Closed -$338K – 122
2025
Q3 		$338K Hold
863
– – 0.43% 75
2025
Q2 		$384K Buy
863
+15
+2% +$6.91K 0.52% 60
2025
Q1 		$411K Sell
848
-1
-0.1% -$466 0.62% 48
2024
Q4 		$342K Hold
849
– – 0.58% 51
2024
Q3 		$395K Buy
849
+17
+2% +$8.17K 0.67% 48
2024
Q2 		$390K Buy
832
+298
+56% +$129K 0.71% 41
2024
Q1 		$223K Buy
+534
New +$226K 0.43% 91

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return